Cytokinetics
CYTK
#2363
Rank
A$11.59 B
Marketcap
A$94.83
Share price
0.84%
Change (1 day)
21.33%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: A$11.59 Billion

As of December 2025 Cytokinetics has a market cap of A$11.59 Billion. This makes Cytokinetics the world's 2363th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025A$11.59 B29.03%
2024A$8.98 B-25.22%
2023A$12.01 B88.58%
2022A$6.37 B20.09%
2021A$5.30 B177.39%
2020A$1.91 B113.31%
2019A$0.89 B82.67%
2018A$0.49 B-12.73%
2017A$0.56 B-17.83%
2016A$0.68 B20.46%
2015A$0.56 B50.2%
2014A$0.37 B69.24%
2013A$0.22 B147.12%
2012A$90.47 M33.69%
2011A$67.67 M-50.84%
2010A$0.13 B-30.65%
2009A$0.19 B-1.61%
2008A$0.20 B-24.34%
2007A$0.26 B-35.08%
2006A$0.41 B71.17%
2005A$0.23 B-32.52%
2004A$0.35 B

End of Day market cap according to different sources

On Dec 20th, 2025 the market cap of Cytokinetics was reported to be:

A$11.59 Billion
by Nasdaq info icon info icon
A$11.59 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
A$5.96 B-48.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A$0.01 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.24 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$266.52 B 2,198.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$2.19 B-81.10%๐Ÿ‡บ๐Ÿ‡ธ USA